Kelly Masone

Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2009

A Study of the HSP90 Inhibitor STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
November 2009 - September 2011
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Sta 9090



